Skip to main content
Premium Trial:

Request an Annual Quote

NCI Grants to Fund Biomolecular Cancer Detection

NEW YORK (GenomeWeb News) – The National Cancer Institute will fund studies that develop high-throughput methods to discover DNA from tumors and exfoliated cells in human fluids with up to $275,000 over two years.

The goal of the "Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis" grant is to develop new enrichment methods to detect very low levels of materials from tumors such as DNA and cells in body fluids such as sputum.

This research could include development of high-throughput technologies for identifying abnormal exfoliated cells in body fluids; molecular, immunologic, or other technologies to isolate tumor cells or biomolecules to detect tumors; and sampling technologies for capturing and preserving exfoliated tumor cells.

These technologies could be used to measure tumor progression, for early detection, for enrichment and detection of cells and biomolecules, and for using PCR or other methods to detect molecular signatures, said NCI.

Filed under

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.